CAH
Price
$130.45
Change
+$5.45 (+4.36%)
Updated
Apr 9 closing price
Capitalization
27.26B
21 days until earnings call
SNYR
Price
$1.79
Change
-$0.21 (-10.50%)
Updated
Apr 9 closing price
Capitalization
494.39K
Ad is loading...

CAH vs SNYR

Header iconCAH vs SNYR Comparison
Open Charts CAH vs SNYRBanner chart's image
Cardinal Health
Price$130.45
Change+$5.45 (+4.36%)
Volume$4.29M
Capitalization27.26B
Synergy CHC
Price$1.79
Change-$0.21 (-10.50%)
Volume$63.23K
Capitalization494.39K
CAH vs SNYR Comparison Chart
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. SNYR commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and SNYR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 10, 2025
Stock price -- (CAH: $125.00 vs. SNYR: $2.00)
Brand notoriety: CAH and SNYR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 185% vs. SNYR: 527%
Market capitalization -- CAH: $27.26B vs. SNYR: $494.39K
CAH [@Medical Distributors] is valued at $27.26B. SNYR’s [@Medical Distributors] market capitalization is $494.39K. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whileSNYR’s FA Score has 0 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • SNYR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CAH and SNYR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 3 TA indicator(s) are bullish while SNYR’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 3 bullish, 5 bearish.
  • SNYR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNYR is a better buy in the short-term than CAH.

Price Growth

CAH (@Medical Distributors) experienced а -8.85% price change this week, while SNYR (@Medical Distributors) price change was -22.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -7.23%. For the same industry, the average monthly price growth was -11.11%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CAH is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Distributors (-7.23% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than SNYR($494K). CAH YTD gains are higher at: 6.535 vs. SNYR (-54.545). CAH has higher annual earnings (EBITDA): 1.89B vs. SNYR (-8.26M). CAH has more cash in the bank: 4.59B vs. SNYR (315K). SNYR has less debt than CAH: SNYR (5.8M) vs CAH (4.72B). CAH has higher revenues than SNYR: CAH (216B) vs SNYR (26M).
CAHSNYRCAH / SNYR
Capitalization27.3B494K5,526,316%
EBITDA1.89B-8.26M-22,912%
Gain YTD6.535-54.545-12%
P/E Ratio44.47N/A-
Revenue216B26M830,769%
Total Cash4.59B315K1,457,460%
Total Debt4.72B5.8M81,431%
FUNDAMENTALS RATINGS
CAH vs SNYR: Fundamental Ratings
CAH
SNYR
OUTLOOK RATING
1..100
7560
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
382
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4434
P/E GROWTH RATING
1..100
8845
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (55) in the Medical Distributors industry is in the same range as SNYR (63) in the null industry. This means that CAH’s stock grew similarly to SNYR’s over the last 12 months.

CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is significantly better than the same rating for SNYR (82) in the null industry. This means that CAH’s stock grew significantly faster than SNYR’s over the last 12 months.

CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as SNYR (100) in the null industry. This means that CAH’s stock grew similarly to SNYR’s over the last 12 months.

SNYR's Price Growth Rating (34) in the null industry is in the same range as CAH (44) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to CAH’s over the last 12 months.

SNYR's P/E Growth Rating (45) in the null industry is somewhat better than the same rating for CAH (88) in the Medical Distributors industry. This means that SNYR’s stock grew somewhat faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHSNYR
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 21 days ago
66%
Bullish Trend 15 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY496.48-7.90
-1.57%
SPDR® S&P 500® ETF
GME23.39-0.90
-3.71%
GameStop Corp
BTC.X76271.950000-2963.382800
-3.74%
Bitcoin cryptocurrency
TSLA221.86-11.43
-4.90%
Tesla
AAPL172.42-9.04
-4.98%
Apple

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-0.54%
COR - CAH
54%
Loosely correlated
+0.06%
MCK - CAH
48%
Loosely correlated
-1.38%
OMI - CAH
13%
Poorly correlated
-4.43%
EDAP - CAH
11%
Poorly correlated
+0.34%
HSIC - CAH
9%
Poorly correlated
-2.50%
More

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and YI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
-1.54%
YI - SNYR
22%
Poorly correlated
-1.62%
COSM - SNYR
18%
Poorly correlated
N/A
ZYXI - SNYR
-0%
Poorly correlated
-2.31%
CAH - SNYR
-3%
Poorly correlated
-0.54%
PDCO - SNYR
-5%
Poorly correlated
+0.68%
More